Intercept Pharmaceuticals

Intercept Pharmaceuticals company information, Employees & Contact Information

We are a biopharmaceutical company and wholly owned subsidiary of Alfasigma S.p.A. focused on the development and commercialization of novel therapeutics to treat rare and serious liver diseases, including primary biliary cholangitis (PBC) and severe alcohol-associated hepatitis (sAH). In a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with rare and serious liver disease. We are committed to improving patients’ lives and addressing the liver community’s most pressing needs. Our corporate headquarters is located in New Jersey. For more information about Intercept, please visit our website at: www.interceptpharma.com and follow us on X at: @InterceptPharma.

Company Details

Employees
346
Founded
-
Address
305 Madison Ave, Morristown,new Jersey 07960,united States
Phone
646-747-1000
Email
in****@****rma.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Morristown, New Jersey
Looking for a particular Intercept Pharmaceuticals employee's phone or email?

Intercept Pharmaceuticals Questions

News

Intercept Announces Voluntary Withdrawal of OCALIVA® for Primary Biliary Cholangitis (PBC) from the US Market; US Clinical Trials Involving Obeticholic Acid Placed on Clinical Hold - Yahoo Finance

Intercept Announces Voluntary Withdrawal of OCALIVA® for Primary Biliary Cholangitis (PBC) from the US Market; US Clinical Trials Involving Obeticholic Acid Placed on Clinical Hold Yahoo Finance

Ocaliva for PBC Withdrawn From US Market - Medscape

Ocaliva for PBC Withdrawn From US Market Medscape

Intercept Receives Complete Response Letter from FDA for Obeticholic Acid for the Treatment of Fibrosis Due to NASH - GlobeNewswire

Intercept Receives Complete Response Letter from FDA for Obeticholic Acid for the Treatment of Fibrosis Due to NASH GlobeNewswire

Intercept Pharmaceuticals Receives FDA Orphan Drug Designation for the Fixed-Dose Combination of OCA and Bezafibrate for the Treatment of Primary Biliary Cholangitis (PBC) - Stock Titan

Intercept Pharmaceuticals Receives FDA Orphan Drug Designation for the Fixed-Dose Combination of OCA and Bezafibrate for the Treatment of Primary Biliary Cholangitis (PBC) Stock Titan

Intercept Appoints M. Michelle Berrey, M.D., M.P.H., as President - citybiz

Intercept Appoints M. Michelle Berrey, M.D., M.P.H., as President citybiz

Analysis Of The Non-alcoholic Steatohepatitis (NASH) Drug Pipeline & Market: The M&A And Commercial Landscape - Pharmaceutical Online

Analysis Of The Non-alcoholic Steatohepatitis (NASH) Drug Pipeline & Market: The M&A And Commercial Landscape Pharmaceutical Online

Modeling and Experimental Studies of Obeticholic Acid Exposure and the Impact of Cirrhosis Stage - Wiley

Modeling and Experimental Studies of Obeticholic Acid Exposure and the Impact of Cirrhosis Stage Wiley

Intercept Announces Advanz Pharma to Acquire Ocaliva in PBC in Markets Outside the U.S. for up to $450MM, including $405MM Upfront and an Additional $45MM in Contingent Payments - Yahoo Finance

Intercept Announces Advanz Pharma to Acquire Ocaliva in PBC in Markets Outside the U.S. for up to $450MM, including $405MM Upfront and an Additional $45MM in Contingent Payments Yahoo Finance

Intercept Provides Regulatory Update Regarding sNDA for OCALIVA - GlobeNewswire

Intercept Provides Regulatory Update Regarding sNDA for OCALIVA GlobeNewswire

Intercept Pharmaceuticals Provides Update on Phase 3 REVERSE Trial in Compensated Cirrhosis Due to NASH - Yahoo Finance

Intercept Pharmaceuticals Provides Update on Phase 3 REVERSE Trial in Compensated Cirrhosis Due to NASH Yahoo Finance

Alfasigma completes acquisition of Intercept Pharmaceuticals, Inc. - GlobeNewswire

Alfasigma completes acquisition of Intercept Pharmaceuticals, Inc. GlobeNewswire

Intercept Announces Positive Data in Fibrosis due to NASH from a New Analysis of its Phase 3 REGENERATE Study of Obeticholic Acid (OCA) - Yahoo Finance

Intercept Announces Positive Data in Fibrosis due to NASH from a New Analysis of its Phase 3 REGENERATE Study of Obeticholic Acid (OCA) Yahoo Finance

Alfasigma to Acquire Intercept Pharmaceuticals for $19.00 - GlobeNewswire

Alfasigma to Acquire Intercept Pharmaceuticals for $19.00 GlobeNewswire

Intercept Pharmaceuticals Announces REVERSE Phase 3 Study - GlobeNewswire

Intercept Pharmaceuticals Announces REVERSE Phase 3 Study GlobeNewswire

Intercept Announces Additional Positive Data in Fibrosis - GlobeNewswire

Intercept Announces Additional Positive Data in Fibrosis GlobeNewswire

Intercept Pharmaceuticals Announces Leadership Transition - GlobeNewswire

Intercept Pharmaceuticals Announces Leadership Transition GlobeNewswire

Findings From COBALT Trial, Including External Control Arm, Published in The American Journal of Gastroenterology - GlobeNewswire

Findings From COBALT Trial, Including External Control Arm, Published in The American Journal of Gastroenterology GlobeNewswire

Intercept Announces Positive Topline Results from Pivotal - GlobeNewswire

Intercept Announces Positive Topline Results from Pivotal GlobeNewswire

FDA Grants Accelerated Approval to Ocaliva™ (Obeticholic Acid) for the Treatment of Patients with PBC - GlobeNewswire

FDA Grants Accelerated Approval to Ocaliva™ (Obeticholic Acid) for the Treatment of Patients with PBC GlobeNewswire

Obeticholic acid yields fewer deaths, liver transplants in primary biliary cholangitis - Healio

Obeticholic acid yields fewer deaths, liver transplants in primary biliary cholangitis Healio

BPS Publications - British Pharmacological Society | Journals

BPS Publications British Pharmacological Society | Journals

Analysis Of The Non-alcoholic Steatohepatitis (NASH) Drug Pipeline & Market: Sizing Up The First Wave - Pharmaceutical Online

Analysis Of The Non-alcoholic Steatohepatitis (NASH) Drug Pipeline & Market: Sizing Up The First Wave Pharmaceutical Online

Top Intercept Pharmaceuticals Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant